Zydus Lifesciences Planning to Acquire LiqMeds Group for Rs 689 Crore
Indian Pharmaceutical major Zydus Lifesciences, on 31 October, announced that its board had approved the acquisition of LiqMeds for Rs 689 crore. The company is...
Use UNICORN Signals App
By EquityPandit
